187 related articles for article (PubMed ID: 21544521)
41. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
42. Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat.
Sobrian SK; Jones BL; Varghese S; Holson RR
Neurotoxicol Teratol; 2003; 25(3):311-28. PubMed ID: 12757828
[TBL] [Abstract][Full Text] [Related]
43. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
Katz JL; Alling KL
Behav Pharmacol; 2000 Sep; 11(6):483-93. PubMed ID: 11103914
[TBL] [Abstract][Full Text] [Related]
44. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
Brudzynski SM; Komadoski M; St Pierre J
Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
[TBL] [Abstract][Full Text] [Related]
45. The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole.
Thacker SK; Perna MK; Ward JJ; Schaefer TL; Williams MT; Kostrzewa RM; Brown RW
Eur J Neurosci; 2006 Oct; 24(7):2075-83. PubMed ID: 17067304
[TBL] [Abstract][Full Text] [Related]
46. Gestational exposure to cocaine or pharmacologically related compounds: effects on behavior and striatal dopamine receptors.
Stewart CW; Scalzo FM; Valentine J; Holson RR; Ali SF; Slikker W
Life Sci; 1998; 63(22):2015-22. PubMed ID: 9839545
[TBL] [Abstract][Full Text] [Related]
47. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
Vorhees CV; Johnson HL; Burns LN; Williams MT
Neurotoxicol Teratol; 2009; 31(1):1-10. PubMed ID: 18930132
[TBL] [Abstract][Full Text] [Related]
48. Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.
Tizabi Y; Copeland RL; Brus R; Kostrzewa RM
Psychopharmacology (Berl); 1999 Aug; 145(4):433-41. PubMed ID: 10460321
[TBL] [Abstract][Full Text] [Related]
49. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
50. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
Boulougouris V; Castañé A; Robbins TW
Psychopharmacology (Berl); 2009 Mar; 202(4):611-20. PubMed ID: 18836703
[TBL] [Abstract][Full Text] [Related]
51. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
52. Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation.
Chen HT; Ruan NY; Chen JC; Lin TY
ASN Neuro; 2012 Sep; 4(6):371-82. PubMed ID: 22909302
[TBL] [Abstract][Full Text] [Related]
53. Opposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats.
Lazenka MF; Legakis LP; Negus SS
Exp Clin Psychopharmacol; 2016 Jun; 24(3):193-205. PubMed ID: 26987070
[TBL] [Abstract][Full Text] [Related]
54. Chronic D1-receptor blockade: effects on D2-receptor agonist-induced yawning in rats.
Hietala J; Lappalainen J; Syvälahti E
J Pharm Pharmacol; 1991 Apr; 43(4):278-9. PubMed ID: 1676742
[TBL] [Abstract][Full Text] [Related]
55. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
Kuo DY
J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
[TBL] [Abstract][Full Text] [Related]
56. Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.
Gill WD; Burgess KC; Vied C; Brown RW
J Psychopharmacol; 2021 Oct; 35(10):1188-1203. PubMed ID: 34291671
[TBL] [Abstract][Full Text] [Related]
57. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
58. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
59. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
60. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Culver KE; Szechtman H
Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
